Covista: 3 Key Takeaways for Long-Term Investors
After Plunging 14.7% in 4 Weeks, Here's Why the Trend Might Reverse for Covista (CVSA)
Is Covista Inc. (CVSA) Outperforming Other Consumer Discretionary Stocks This Year?
CVSA Q3 deep dive: Healthcare enrollment growth and campus expansion drive guidance lift
The 5 most interesting analyst questions from Covista’s Q3 earnings call
Covista Inc. 2027 Q1 - Results - Earnings Call Presentation
Is Covista (CVSA) Undervalued As Earnings Beat And Higher Guidance Lift The Stakes?
Covista (CVSA) Stock Looks Undervalued As Earnings Expectations Improve
What Covista (CVSA)'s Raised 2027 Guidance Means For Shareholders
Covista (CVSA) Q1 2027 Earnings Call Transcript
Covista: Stronger Results Keep Me Bullish, But Cash Flow Needs To Improve
Covista Inc (NYSE:CVSA) Posts Beat-and-Raise Quarter as Enrollment Growth Continues
Covista (CVSA) Beats Q1 Earnings and Revenue Estimates
Covista: Fiscal Q1 Earnings Snapshot
Covista (NYSE:CVSA) beats Q3 CY2026 sales expectations
Covista Reports First Quarter Fiscal Year 2027 Results; Raises Fiscal Year 2027 Revenue and Adjusted EPS Guidance
Covista Inc. (CVSA) Q1 2027 Earnings Call Transcript
Covista Q1 2027 Earnings Call Transcript
Covista Raises FY2027 Adj EPS Guidance from $8.90-$9.15 to $9.00-$9.20 vs $9.04 Est; Raises FY2027 Sales Guidance from $2.050B-$2.090B to $2.060B-$2.095B vs $2.065B Est
Covista Q1 Adj. EPS $2.19 Beats $1.83 Estimate, Sales $511.534M Beat $488.368M Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.